MARKET

BHVN

BHVN

Biohaven
NYSE
14.72
-0.97
-6.18%
After Hours: 14.84 +0.12 +0.81% 19:59 09/08 EDT
OPEN
14.91
PREV CLOSE
15.69
HIGH
15.80
LOW
14.33
VOLUME
3.31M
TURNOVER
--
52 WEEK HIGH
18.57
52 WEEK LOW
7.48
MARKET CAP
2.22B
P/E (TTM)
-3.1693
1D
5D
1M
3M
1Y
5Y
1D
Biohaven downgraded at RBC Capital Markets after SK Biopharma deal
Seeking Alpha · 14h ago
Biohaven downgraded to Sector Perform from Outperform at RBC Capital
TipRanks · 21h ago
Weekly Report: what happened at BHVN last week (0831-0904)?
Weekly Report · 1d ago
Weekly Report: what happened at BHVN last week (0824-0828)?
Weekly Report · 08/31 10:02
Analysts Are Bullish on These Healthcare Stocks: Globus Medical (GMED), Biohaven Ltd. (BHVN)
TipRanks · 08/28 12:40
Biohaven: Buy Reiterated On Opakalim License Agreement For Epilepsy And More
Seeking Alpha · 08/27 18:21
Biohaven: Sale Of Opakalim Rights To SK Biopharmaceuticals Makes Sense On Many Levels
Seeking Alpha · 08/27 15:30
Biohaven: Opakalim Deal Seen as Strategically Neutral; Sell Rating Reiterated with Unchanged $11 Price Target
TipRanks · 08/27 08:35
More
About BHVN
Biohaven Ltd. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments in key therapeutic areas, including immunology, neuroscience, and oncology. It is advancing its portfolio of therapeutics, leveraging its drug development experience and multiple proprietary drug development platforms. Its clinical and preclinical programs include Kv7 ion channel modulation for epilepsy; Molecular Degrader of Extracellular Proteins (MoDE) and Targeted Removal of Aberrant Protein (TRAP) extracellular protein degradation for immunological diseases; and myostatin-activin pathway targeting agent for neuromuscular and metabolic diseases, including obesity. Its pipeline includes TYK2/JAK1 Inhibitor (brain-penetrant), IgG Degrader, Gd-IgA1 TRAP Degrader, Taldefgrobep Alfa, Kv7 Activator, TRPM3 Antagonist FGFR3 ADC, CD30 ADC, Trop2 ADC +/- PD1, and others. Its advanced product candidate from its glutamate receptor antagonist platform is troriluzole.

Webull offers Biohaven Ltd stock information, including NYSE: BHVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BHVN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BHVN stock methods without spending real money on the virtual paper trading platform.